BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  AMGEN PRESENTS NEW DATA FOR FIRST-IN-CLASS IMDELLTRA™ (TARLATAMAB-DLLE) IN SMALL CELL LUNG CANCER AT WCLC 2024

  September 9, 2024

   · 

  30 min read
• Press Releases

  Exactech Unveils Pioneering AI and Radiomics Research for Shoulder Arthroplasty, Highlights Advances in Knee and Ankle Technologies

  September 9, 2024

   · 

  2 min read
• Press Releases

  IBRILATAZAR (ABTL0812) from AbilityPharma increases chemotherapy effectiveness by 40% in patients with endometrial cancer

  September 9, 2024

   · 

  5 min read
• Press Releases

  SystImmune, Inc. to Present New BL-B01D1 Data in Urothelial, Biliary Tract, and Esophageal Squamous Cell Carcinoma at ESMO Congress 2024

  September 9, 2024

   · 

  5 min read
• Press Releases

  Lilly appoints Lucas Montarce as executive vice president and chief financial officer

  September 9, 2024

   · 

  3 min read
• Press Releases

  BriaCell Announces Presentation at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

  September 9, 2024

   · 

  3 min read
• Press Releases

  RIGImmune Announces Multiple Oral Presentations for Intranasal RIG-101 at European Respiratory Society Congress 2024

  September 9, 2024

   · 

  9 min read
• Press Releases

  Medicenna Presents Preclinical Results from its IL-2 Super-Antagonist and Anti-PD1-IL-2 BiSKIT Programs at The Promise of Interleukin-2 Therapy Conference

  September 9, 2024

   · 

  9 min read
• Press Releases

  Theratechnologies to Present at Upcoming Investor Conferences in September

  September 9, 2024

   · 

  1 min read
• Press Releases

  Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaenoic Acid (EPA) to be Presented at the 60th Annual European Association for the Study of Diabetes (EASD) Meeting

  September 9, 2024

   · 

  8 min read